The American Journal of Medicine
Volume 110, Issue 7 , Pages 543-550 , May 2001

A case-management program of medium intensity does not improve cardiovascular risk factor control in coronary artery disease patients: the Heartcare I Trial

  • Alain Nordmann, MD

      Affiliations

    • Medical Outpatient Division, Department of Internal Medicine, University Hospital, Basel, Switzerland
    • Equally contributed to this article.
    • ,
  • Iris Heilmbauer, MD

      Affiliations

    • Medical Outpatient Division, Department of Internal Medicine, University Hospital, Basel, Switzerland
    • ,
  • Tobias Walker, MD

      Affiliations

    • Medical Outpatient Division, Department of Internal Medicine, University Hospital, Basel, Switzerland
    • ,
  • Benedict Martina, MD

      Affiliations

    • Medical Outpatient Division, Department of Internal Medicine, University Hospital, Basel, Switzerland
    • ,
  • Edouard Battegay, MD

      Affiliations

    • Medical Outpatient Division, Department of Internal Medicine, University Hospital, Basel, Switzerland
    • Corresponding Author InformationRequests for reprints should be addressed to Edouard Battegay, MD, Medical Outpatient Division, Department of Internal Medicine, University Hospital, CH-4031 Basel, Switzerland

Received 16 October 2000 ,Revised 29 January 2001 ,Accepted 29 January 2001.

References 

  1. Scandinavian Simvastatin Survival Study Group (4S) . Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet. 1994;344:1383–1389
  2. Cholesterol and Recurrent Events Trial Investigators . The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001–1009
  3. West of Scotland Coronary Prevention Study Group Shepherd J, Cobbe SM, Ford I, et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301–1307
  4. DeBusk RF, Miller NH, Superko HR, et al.  A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med. 1994;120:721–729
  5. Battegay E, Gasche A, Zimmerli L, et al.  Risk factor control and perceptions of risk factors in patients with coronary heart disease. Blood Pressure. 1997;6(suppl 1):17–22
  6. Niebauer J, Hambrecht R, Velich T, et al.  Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention. Circulation. 1997;96:2534–2541
  7. Bondestam E, Breikss A, Hartford M. Effects of early rehabilitation on consumption of medical care during the first year after acute myocardial infarction in patients >65 years of age. Am J Cardiol. 1995;75:767–771
  8. Friedman DB, Williams AN, Levine BD. Compliance and efficacy of cardiac rehabilitation and risk factor modification in the medically indigent. Am J Cardiol. 1997;79:281–285
  9. Carleton RA, Bazzare T, Drake J, et al.  Report of the expert panel on awareness and behavior change to the board of directors, American Heart Association. Circulation. 1996;93:1768–1772
  10. Feder G, Griffiths C, Eldridge S, Spence M. Effect of postal prompts to patients and general practicioners on the quality of primary care after a coronary event (POST) (randomised controlled trial). BMJ. 1999;318:1522–1526
  11. Jolly K, Bradley F, Sharp S, et al.  Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina (final results of the Southhampton Heart Integrated Care Project (SHIP)). BMJ. 1999;318:706–711
  12. Ammerman AS, Haines PS, DeVellis RF, et al.  A brief dietary assessment to guide cholesterol reduction in low-income individuals (design and validation). J Am Diet Assoc. 1991;91:1385–1390
  13. Arbeitsgruppe Lipide der Schweizerischen Gesellschaft für Kardiologie und der Schweizerischen Ärztestiftung . Lipide und Präven-tion der koronaren Herzkrankheit (Diagnostik und Massnahmen, aktualisierte Empfehlungen, Juni 1992). Schweiz Ärztezeitung. 1992;73:1593–1602
  14. Arbeitsgruppe Lipide der Schweizerischen Gesellschaft für Kardiologie . Rolle von Risikofaktoren für die koronare Herzkrankheit. Schweiz Aerztezeitung. 1995;76:497–507
  15. Ahnve S, Angelin B, Edhag O, Berglund L. Early determination of serum lipids and apolipoproteins in acute myocardial infarction (possibility for immediate intervention). J Intern Med. 1989;226:297–301
  16. Carlsson R, Lindberg G, Westin L, Israelsson B. Serum lipids four weeks after myocardial infarction are a valid basis for lipid lowering intervention in patients receiving thrombolysis. Br Heart J. 1995;74:18–20
  17. Altman DG. Clinical trials. Sample size. In:  Altman DB editors. Practical Statistics for Medical Research. 1st ed. London: Chapman & Hall; 1991;p. 455–466
  18. Holms S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65–70
  19. Blankenhorn DH, Johnson RL, Mack WJ, et al.  The influence of diet on the appearance of new lesions in human coronary arteries. JAMA. 1990;263:1646–1656
  20. Watts GF, Lewis B, Brunt JNH, et al.  Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas’ Atherosclerosis Regression Study (STARS). Lancet. 1992;339:563–569
  21. Schuler G, Hambrecht R, Schlierf G, et al.  Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet. J Am Coll Cardiol. 1992;19:34–42
  22. Ornish D, Brown SE, Sherwitz LW, et al.  Can lifestyle changes reverse coronary heart disease?. Lancet. 1990;336:129–133
  23. De Lorgeril M, Renaud S, Mamelle L, et al.  Mediterranean alpha-linoleic acid rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343:1454–1459
  24. Burr ML, Gilbert JF, Rogers S, et al.  Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction (Diet and Reinfarction Trial (DART)). Lancet. 1989;2:757–761
  25. Wallner S, Watzinger N, Lindschinger M, et al.  Effects of intensified lifestyle modification on the need for further revascularization after coronary angioplasty. Eur J Clin Invest. 1999;29:372–379
  26. Ebrahim S, Smith GD. Lowering blood pressure (a systematic review of sustained effects of non-pharmacological interventions). J Publ Health Med. 1998;20:441–448
  27. Becker DM, Raqueno JV, Yook RM, et al.  Nurse-mediated cholesterol management compared with enhanced primary care in siblings of individuals with premature coronary disease. Arch Intern Med. 1998;158:1533–1539
  28. Wasson J, Gaudette C, Whaley F, et al.  Telephone care as a substitute for routine clinic follow-up. JAMA. 1992;267:1788–1793
  29. Haskell WL, Alderman EL, Fair JM, et al.  Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 1994;89:975–990
  30. Benson VM. Dyslipidemia treatment guidelines and management systems in Kaiser Permanente. Am J Cardiol. 1997;80:85H–88H
  31. Thomas TS. Improving care with nurse case managers (practical aspects of designing lipid clinics). Am J Cardiol. 1997;80:62H–65H
  32. Nordmann A, Blattmann L, Gallino A, et al.  Systematic, immediate in-hospital initiation of lipid-lowering drugs during acute coronary events improves lipid control. Eur J Int Med. 2000;11:309–316

☆ Supported by a grant (96-8068) from the Swiss Federal Office of Health, a study grant (48602) from the University Hospital, Basel, Switzerland, and an unrestricted study grant from Merck, Sharp & Dohme, Switzerland. Dr. Battegay was a recipient of a SCORE grant (32-31948.91) of the Swiss National Science Foundation.

PII: S0002-9343(01)00682-9

The American Journal of Medicine
Volume 110, Issue 7 , Pages 543-550 , May 2001

Article Tools